EGFR and lung cancer: For instance, drug-induced tumor apoptosis may occur for EGFR-targeted therapy in lung cancer within days of initial dosing, and daily sampling of ctDNA may facilitate early assessment of patient response within the first week of treatment with EGFR inhibitors [10].